Cite

HARVARD Citation

    Gürbüz, M. et al. (2021). Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer. Tumori. 107 (5), pp. 416-423. [Online]. 
  
Back to record